214 related articles for article (PubMed ID: 22717543)
41. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis.
Furuhashi M; Fuseya T; Murata M; Hoshina K; Ishimura S; Mita T; Watanabe Y; Omori A; Matsumoto M; Sugaya T; Oikawa T; Nishida J; Kokubu N; Tanaka M; Moniwa N; Yoshida H; Sawada N; Shimamoto K; Miura T
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):825-34. PubMed ID: 27013610
[TBL] [Abstract][Full Text] [Related]
42. Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.
Lázaro I; Díaz M; Cabré A; Masana L; Ibáñez L
Gynecol Endocrinol; 2011 Nov; 27(11):935-9. PubMed ID: 21605000
[TBL] [Abstract][Full Text] [Related]
43. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study.
Kaess BM; Enserro DM; McManus DD; Xanthakis V; Chen MH; Sullivan LM; Ingram C; O'Donnell CJ; Keaney JF; Vasan RS; Glazer NL
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1943-7. PubMed ID: 22855337
[TBL] [Abstract][Full Text] [Related]
44. Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages.
Furuhashi M; Ogura M; Matsumoto M; Yuda S; Muranaka A; Kawamukai M; Omori A; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Harada-Shiba M; Shimamoto K; Miura T
Sci Rep; 2017 Mar; 7(1):217. PubMed ID: 28303004
[TBL] [Abstract][Full Text] [Related]
45. Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria.
Tanaka M; Furuhashi M; Moniwa N; Maeda T; Takizawa H; Matsumoto M; Sakai A; Higashiura Y; Gocho Y; Koyama M; Ogawa Y; Miura T
BMC Nephrol; 2020 Nov; 21(1):459. PubMed ID: 33143633
[TBL] [Abstract][Full Text] [Related]
46. Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.
Okazaki Y; Furuhashi M; Tanaka M; Mita T; Fuseya T; Ishimura S; Watanabe Y; Hoshina K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
PLoS One; 2014; 9(12):e115429. PubMed ID: 25506691
[TBL] [Abstract][Full Text] [Related]
47. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women.
Terra X; Quintero Y; Auguet T; Porras JA; Hernández M; Sabench F; Aguilar C; Luna AM; Del Castillo D; Richart C
Eur J Endocrinol; 2011 Apr; 164(4):539-47. PubMed ID: 21257725
[TBL] [Abstract][Full Text] [Related]
48. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.
Iimura O; Shimamoto K; Matsuda K; Masuda A; Takizawa H; Higashiura K; Miyazaki Y; Hirata A; Ura N; Nakagawa M
Am J Hypertens; 1995 Apr; 8(4 Pt 1):353-7. PubMed ID: 7619347
[TBL] [Abstract][Full Text] [Related]
49. Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.
Karakas SE; Banaszewska B; Spaczynski RZ; Pawelczyk L; Duleba A
Gynecol Endocrinol; 2013 May; 29(5):483-7. PubMed ID: 23480783
[TBL] [Abstract][Full Text] [Related]
50. Effects of a calcium channel blocker, manidipine, on insulin sensitivity in essential hypertensives.
Iimura O; Shimamoto K; Masuda A; Higashiura K; Miyazaki Y; Hirata A; Fukuoka M; Murakami H
J Diabetes Complications; 1995; 9(4):215-9. PubMed ID: 8573730
[TBL] [Abstract][Full Text] [Related]
51. [Association of serum leptin concentrations with blood pressure].
Wang G; Tang J; Chen M
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):664-7. PubMed ID: 11715454
[TBL] [Abstract][Full Text] [Related]
52. Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease.
Wang CP; Hsu CC; Hung WC; Yu TH; Wu CC; Tsai IT; Tang WH; Chung FM; Houng JY; Lee YJ; Lu YC
BMC Cardiovasc Disord; 2019 Jun; 19(1):153. PubMed ID: 31234795
[TBL] [Abstract][Full Text] [Related]
53. Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.
Gormez S; Erdim R; Akan G; Caynak B; Duran C; Gunay D; Sozer V; Atalar F
Cardiovasc Pathol; 2020; 46():107192. PubMed ID: 31927390
[TBL] [Abstract][Full Text] [Related]
54. Lipoprotein apheresis reduces adipocyte fatty acid-binding protein serum levels.
Lamounier-Zepter V; Look C; Ehrhart-Bornstein M; Bornstein SR; Fischer S; Julius U
Atheroscler Suppl; 2013 Jan; 14(1):129-34. PubMed ID: 23357154
[TBL] [Abstract][Full Text] [Related]
55. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.
Andrés Cerezo L; Kuklová M; Hulejová H; Vernerová Z; Pešáková V; Pecha O; Veigl D; Haluzík M; Pavelka K; Vencovský J; Senolt L
Cytokine; 2013 Oct; 64(1):441-7. PubMed ID: 23714112
[TBL] [Abstract][Full Text] [Related]
56. [The role of hyperinsulinemia on the renal mechanism of hyperuricemia in overweight patients with essential hypertension].
Takada T; Kikuchi K; Hasegawa T; Komura H; Suzuki S; Satoh N; Ohotomo T; Nanba M; Marusaki S; Iimura O
Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):861-70. PubMed ID: 1813326
[TBL] [Abstract][Full Text] [Related]
57. Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus.
Duan B; Li Y; Dong K; Sun Y; Ma A; Yang X
Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102213. PubMed ID: 33260074
[TBL] [Abstract][Full Text] [Related]
58. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.
Rodríguez-Calvo R; Girona J; Rodríguez M; Samino S; Barroso E; de Gonzalo-Calvo D; Guaita-Esteruelas S; Heras M; van der Meer RW; Lamb HJ; Yanes O; Correig X; Llorente-Cortés V; Vázquez-Carrera M; Masana L
Metabolism; 2019 Jul; 96():12-21. PubMed ID: 30999003
[TBL] [Abstract][Full Text] [Related]
59. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.
Furuhashi M; Saitoh S; Shimamoto K; Miura T
Clin Med Insights Cardiol; 2014; 8(Suppl 3):23-33. PubMed ID: 25674026
[TBL] [Abstract][Full Text] [Related]
60. Maternal serum fatty acid binding protein 4 (FABP4) and the development of preeclampsia.
Scifres CM; Catov JM; Simhan H
J Clin Endocrinol Metab; 2012 Mar; 97(3):E349-56. PubMed ID: 22188744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
